HHS proposal for drug price transparency in Medicaid

A new proposal from the US Department of Health and Human Services (HHS) is proposing steps to further drive down prescription drug costs in Medicaid, building on the Biden administration’s widespread efforts to lower medicine prices.

The HHS’ Centers for Medicare & Medicaid Services’ (CMS) latest notice of proposed rulemaking would shed light on the actual cost of drugs covered by Medicaid.

Under this proposal, Medicaid would have increased ability to hold drug manufacturers accountable for what the program pays for drugs.